Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

URMEEL HASMUKH PATEL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1013263110
CMS profile
534521
Location
SHENANDOAH, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$18,956.92

334 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $10,107.50 4
Food and Beverage $6,748.91 318
Travel and Lodging $1,583.56 9
Honoraria $360.00 1
Education $156.95 2

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Bayer Healthcare Pharmaceuticals Inc. $6,982.01 12
AstraZeneca Pharmaceuticals LP $3,859.92 25
Janssen Biotech, Inc. $1,843.83 11
Daiichi Sankyo Inc. $504.03 9
Amgen Inc. $412.34 22
Novartis Pharmaceuticals Corporation $403.71 21
PFIZER INC. $381.76 25
GlaxoSmithKline, LLC. $357.30 12
Astellas Pharma US Inc $331.50 18
Celgene Corporation $330.81 16
GENZYME CORPORATION $318.74 11
E.R. Squibb & Sons, L.L.C. $173.22 16
Lilly USA, LLC $170.14 8
Eisai Inc. $169.44 10
Myriad Genetic Laboratories, Inc. $168.85 5
Stemline Therapeutics Inc. $149.35 10
Regeneron Pharmaceuticals, Inc. $141.77 1
Gilead Sciences, Inc. $138.25 7
SOBI, INC $124.52 5
Regeneron Healthcare Solutions, Inc. $116.63 4
Genentech USA, Inc. $110.92 5
Mirati Therapeutics, Inc. $108.94 1
ABBVIE INC. $103.23 5
Takeda Pharmaceuticals U.S.A., Inc. $98.80 4
Merck Sharp & Dohme LLC $97.55 5
Emmaus Medical, Inc. $94.91 3
Pharmacyclics LLC, An AbbVie Company $90.16 3
Seagen Inc. $88.01 5
TAIHO ONCOLOGY, INC. $64.23 4
CTI BioPharma Corp. $63.56 3
ARRAY BIOPHARMA INC $62.26 4
AVEO Pharmaceuticals, Inc. $61.71 3
MorphoSys, US Inc. $59.90 3
Deciphera Pharmaceuticals Inc. $56.52 2
Blueprint Medicines Corporation $54.89 2
Puma Biotechnology, Inc. $54.73 3
Dendreon Pharmaceuticals LLC $53.92 2
PharmaEssentia USA Corporation $51.23 2
Adaptive Biotechnologies Corporation $43.42 2
BeiGene USA, Inc. $41.43 2
Alexion Pharmaceuticals, Inc. $39.30 2
Karyopharm Therapeutics Inc. $35.35 2
Sirtex Medical Inc $30.20 2
Rigel Pharmaceuticals, Inc. $29.49 1
Ipsen Biopharmaceuticals, Inc $27.51 2
Shield Therapeutics Inc $24.26 1
TerSera Therapeutics LLC $22.98 1
G1 Therapeutics, Inc. $22.28 1
Alnylam Pharmaceuticals Inc. $21.93 1
EMD Serono, Inc. $21.27 1
Verity Pharmaceuticals Inc. $21.02 1
Kyowa Kirin, Inc. $20.63 1
JAZZ PHARMACEUTICALS INC. $16.55 1
Sun Pharmaceutical Industries Inc. $15.47 1
Spectrum Pharmaceuticals Inc. $14.74 1
Kite Pharma, Inc. $14.48 1
Incyte Corporation $14.38 1
Pharming Healthcare, Inc. $13.83 1
ADC Therapeutics America, Inc. $12.81 1

Page 5 of 7; records 201–250 of 334 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

URMEEL HASMUKH PATEL

NPI 1013263110 · CMS profile ID 534521

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

SHENANDOAH, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 7; records 201–250 of 334 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1013263110?year=2023&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
URMEEL HASMUKH PATEL, NPI 1013263110, CMS profile ID 534521. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 7; records 201–250 of 334 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1013263110?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). URMEEL HASMUKH PATEL, NPI 1013263110, CMS profile ID 534521. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 7; records 201–250 of 334 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1013263110?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
URMEEL HASMUKH PATEL, NPI 1013263110, CMS profile ID 534521, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 7; records 201–250 of 334 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1013263110?year=2023&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

334 matching records · $18,956.92 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 334 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 334.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $19.9605/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048265231 CMS
Amgen Inc. $10.3105/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020181789 CMS
Astellas Pharma US Inc $7.2705/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034122579 CMS
Celgene Corporation $19.5805/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015454437 CMS
ARRAY BIOPHARMA INC $1.4805/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049233055 CMS
ARRAY BIOPHARMA INC $8.2205/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050618855 CMS
GlaxoSmithKline, LLC. $21.9905/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000994513 CMS
PFIZER INC. $3.4505/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049557847 CMS
PFIZER INC. $6.4005/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050623229 CMS
PFIZER INC. $21.3705/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049451191 CMS
Janssen Biotech, Inc. $21.2305/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988430755 CMS
Puma Biotechnology, Inc. $19.2205/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059055593 CMS
Regeneron Healthcare Solutions, Inc. $18.7205/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999357565 CMS
Amgen Inc. $9.5705/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020693151 CMS
Eisai Inc. $22.4605/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023335903 CMS
GlaxoSmithKline, LLC. $23.9905/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000993969 CMS
Karyopharm Therapeutics Inc. $20.7905/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056910237 CMS
AstraZeneca Pharmaceuticals LP $23.9505/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016237923 CMS
GENZYME CORPORATION $22.5105/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050302993 CMS
Lilly USA, LLC $18.4005/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032256469 CMS
Gilead Sciences, Inc. $19.8105/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025822959 CMS
ABBVIE INC. $19.1505/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998099771 CMS
Adaptive Biotechnologies Corporation $29.0805/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022979627 CMS
AstraZeneca Pharmaceuticals LP $22.1305/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011305679 CMS
Puma Biotechnology, Inc. $18.2905/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059063453 CMS
Alexion Pharmaceuticals, Inc. $17.1204/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016993689 CMS
Amgen Inc. $20.3904/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020181765 CMS
Daiichi Sankyo Inc. $20.4504/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006352999 CMS
Spectrum Pharmaceuticals Inc. $14.7404/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059885465 CMS
Amgen Inc. $7.4404/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020181785 CMS
Novartis Pharmaceuticals Corporation $21.2004/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992765605 CMS
E.R. Squibb & Sons, L.L.C. $15.1204/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015454401 CMS
PFIZER INC. $10.6504/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049332699 CMS
Stemline Therapeutics Inc. $14.9304/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040041023 CMS
Merck Sharp & Dohme LLC $14.8304/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048265233 CMS
Astellas Pharma US Inc $17.1704/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034059335 CMS
AstraZeneca Pharmaceuticals LP $22.8604/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016160351 CMS
Daiichi Sankyo Inc. $3.7304/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006345431 CMS
GENZYME CORPORATION $28.1704/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050303001 CMS
Daiichi Sankyo Inc. $26.0704/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006352935 CMS
AstraZeneca Pharmaceuticals LP $20.5804/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014232139 CMS
Blueprint Medicines Corporation $22.9804/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051260087 CMS
G1 Therapeutics, Inc. $22.2804/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059918273 CMS
E.R. Squibb & Sons, L.L.C. $9.6804/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015454407 CMS
Pharming Healthcare, Inc. $13.8304/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1029345215 CMS
Lilly USA, LLC $25.4004/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032243749 CMS
PFIZER INC. $12.2404/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050685119 CMS
Dendreon Pharmaceuticals LLC $25.7504/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060289291 CMS
Merck Sharp & Dohme LLC $15.9504/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048265229 CMS
SOBI, INC $32.4904/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038088351 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,989.58 78
PY2020 $1,635.84 91
PY2021 $3,616.69 189
PY2022 $4,947.32 249
PY2023 $18,956.92 334
PY2024 $20,409.47 292
PY2025 $13,641.48 247

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $35,797.59 2
PY2024 Principal investigator $76,129.42 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $1,107.99 08/31/2025 Non-covered Recipient Entity
Millennium Research & Clinical Development
A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants with EGFR-mutated, Advanced Non-squamous Non-small Cell Lung Cancer NSCLC Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors No dispute reported 06/30/2026 1232923542
Principal investigator 1 Merck Sharp & Dohme LLC $34,689.60 08/31/2025 Non-covered Recipient Entity
Millennium Research & Clinical Development
A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB N2 NSCLC not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Follow No dispute reported 06/30/2026 1232924254